Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Procaps Group, S.A. (PROCF : OTC)
 
 • Company Description   
Procaps Group is a developer of pharmaceutical and nutraceutical solutions, medicines and hospital supplies. It develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps Group, formerly known as Union Acquisition Corp. II, is based in BARRANQUILLA, Colombia.

Number of Employees:

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.29 Daily Weekly Monthly
20 Day Moving Average: 123 shares
Shares Outstanding: 2,303.86 (millions)
Market Capitalization: $2,971.99 (millions)
Beta: 57.03
52 Week High: $1.60
52 Week Low: $0.01
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 5,060.00% 4,969.29%
12 Week 12,672.28% 11,501.75%
Year To Date -44.87% -50.78%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
9 RUE DE BITBOURG
-
LUXEMBOURG,N4 L-1273
LUX		 ph: 356 7995-6138
fax: -		 ir@procapsgroup.com http://www.procapsgroup.com
 
 • General Corporate Information   
Officers
Ruben Minski - Chief Executive Officer and Chairman
Camilo Camacho - Chief Operations Officer
Patricio Vargas Munoz - Chief Financial Officer
Carlos Piocuda Russo - Vice-President
Manuel Jose Vial Claro - Director

Peer Information
Procaps Group, S.A. (GSAC)
Procaps Group, S.A. (CASI)
Procaps Group, S.A. (ALCD.)
Procaps Group, S.A. (OMNN)
Procaps Group, S.A. (CGPI.)
Procaps Group, S.A. (CATX)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-DRUGS
Sector: Medical
CUSIP: L7756P102
SIC: 2834
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: -
Next Expected EPS Date: -
Share - Related Items
Shares Outstanding: 2,303.86
Most Recent Split Date: (:1)
Beta: 57.03
Market Capitalization: $2,971.99 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: -  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 2.49
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -
12/31/24 - -
ROA
06/30/25 - -
03/31/25 - -
12/31/24 - -
Current Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Quick Ratio
06/30/25 - -
03/31/25 - -
12/31/24 - -
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - -
12/31/24 - -
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Capital
06/30/25 - -
03/31/25 - -
12/31/24 - -
 

Powered by Zacks Investment Research ©